Home
About
Pricing
Log In
Back
ATHO
Asset Logo

Alterity Therapeutics Limited

πŸ‡¦πŸ‡Ί ASX

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 235.88%
Annual Growth

2 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Alterity Therapeutics Limited - Option Expiring 31-Aug-2026

πŸ“ˆ Performance

Price History

+400.00%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.01

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in ATHO

1

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in ATHO

N/A
ATHO investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in ATHO also invest in...

Audinate Group Limited

AD8

Audinate Group Ltd. engages in the provision of development and commercialization of audio-visual software and hardware. Its principal activity is the development and sale of digital Audio Visual (AV) networking solutions. Dante is its technology platform that distributes digital audio and video signals over computer networks. Dante comprises software and chips, cards and modules that are sold to and integrated inside the AV products of its original equipment manufacturer customers. The company also provides a series of products and services to AV professionals, including AVIO adapters and management and control software. Its Dante IP networking solution is used in the professional live sound, commercial installation, broadcast, public address, and recording industries. Dante replaces traditional analogue audio cables by transmitting perfectly synchronized audio signals across large distances, to multiple locations at once, using nothing more than an Ethernet cable. The company also offers AI-powered, cloud-based camera control technology.

πŸ™Œ Performance (5Yr p.a)

-4.05%

πŸ“Š Share price

$4.61 AUD

πŸ”¨ COMMERCIAL SERVICES & SUPPLIES

Find Out More

ANZ Group Holdings Ltd. operates as a non-operating holding company. Its divisions include Australia Retail, Australia Commercial, Institutional, New Zealand, Suncorp Bank, Pacific, and Group Center. The Australia Retail division provides a full range of banking services to Australian consumers. This includes Home Loans, Deposits, Credit Cards and Personal Loans. The Australia Commercial division offers a range of banking products and financial services. The Institutional division services institutional and corporate customers, and governments across Australia, New Zealand and International, including Papua New Guinea, via the business units, such as Transaction Banking, Corporate Finance, and Markets. New Zealand division comprises of business unit, such as Personal and Business & Agri. The Suncorp Bank division provides banking and related services to retail, commercial, small and medium enterprises and agribusiness customers in Australia.

πŸ™Œ Performance (5Yr p.a)

19.09%

πŸ“Š Share price

$33.39 AUD

🏦 BANKING

🌳 ENVIRONMENTAL

πŸ•ŠοΈ SOCIALLY AWARE

πŸƒ HIGH ESG SCORE

πŸ“ˆ HIGH PRICE GROWTH

Calix Ltd. engages in the development of patent-protected, platform technology that produces new materials and processes to solve global challenges. The company is headquartered in Pymble, New South Wales. The company went IPO on 2018-07-20. The firm is engaged in solving global challenges in industrial decarbonization and sustainability. Its segments include Leilac (a CO2 mitigation business), Sustainable Processing, Advanced Batteries and Magnesia. The Leilac segment is accelerating the transition to net-zero by providing the most compelling decarbonization solution for global cement and lime. The Sustainable Processing segment enables mineral processing to enter the electric age with applications targeting green iron and steel, zero emissions alumina, and sustainable lithium and other critical minerals. The Advanced Batteries segment is focused on the development of cathode materials. Magnesia segment offers safe and sustainable magnesium-based products solving global environmental challenges in water and agriculture. In addition, it develops and commercializes applications for antimicrobial resistance and sustainable processing of magnesium metal.

πŸ™Œ Performance (5Yr p.a)

-11.67%

πŸ“Š Share price

$0.38 AUD

πŸ§ͺ CHEMICALS

Carnegie Clean Energy Ltd. engages in the development and ownership of the patented CETO wave energy technology. The firm is the owner and developer of the CETO and MoorPower technologies, which capture energy from ocean waves and convert it into electricity. CETO is its core wave energy technology, a submerged point absorber type wave energy converter which converts ocean waves into zero-emission electricity. MoorPower is a CETO derived wave energy technology designed to deliver a sustainable energy supply for marine industries operating at a fixed moored location, reducing the reliance on diesel. The Mooring Tensioner is a component which provides passive tension required for rotary electric power take-off systems, such as is required for CETO and MoorPower. Its projects include ACHIEVE Programme, MoorPower Scaled Demonstrator, Garden Island Microgrid, Microsoft AI for Earth project, CETO Next Generation and others.

πŸ™Œ Performance (5Yr p.a)

1446.67%

πŸ“Š Share price

$0.11 AUD

πŸ”‹ UTILITIES

ASIA.AX was created on 2018-09-18 by BetaShares. The fund's investment portfolio concentrates primarily on information technology equity. The investment objective of the BetaShares Asia Technology Tigers ETF is to provide an investment return that aims to track the performance of the Solactive Asia ex-Japan Technology & Internet Tigers Index (the Index), before taking into account fees and expenses.

πŸ™Œ Performance (5Yr p.a)

9.03%

πŸ“Š Share price

$14.14 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡¦πŸ‡Ί EX AUSTRALIA

Want more shares? Try these...

πŸ“Š Share price

$0.00 AUD

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-03-28. The firm is focused on developing disease modifying treatments for neurodegenerative diseases. The firm's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The firm also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.

πŸ™Œ Performance (5Yr p.a)

-16.00%

πŸ“Š Share price

$0.01 AUD

🧬 BIOTECHNOLOGY

Compare
Add to watchlist